A detailed history of Bivin & Associates, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Bivin & Associates, Inc. holds 200 shares of DHR stock, worth $46,256. This represents 0.05% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$46,256
Previous $59,000 13.56%
% of portfolio
0.05%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $58,416 - $65,802
200 New
200 $66,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bivin & Associates, Inc. Portfolio

Follow Bivin & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bivin & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bivin & Associates, Inc. with notifications on news.